Johnson & Johnson has been instrumental in helping bring us closer to a TB-free world through its groundbreaking work with multidrug-resistant TB—and now a promising single-pill treatment that's being investigated.
In just two years, a unique collaboration has had an unprecedented impact in the fight against the national epidemic. In honor of World TB Day on March 24, we traveled to one of its most affected provinces to report on the project’s remarkable results.